よむ、つかう、まなぶ。
04.【資料2-1】標準的な健診・保健指導プログラム(令和6年度版)(案)1／2 (142 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_31652.html |
| 出典情報 | 標準的な健診・保健指導プログラム改訂に関するワーキンググループ（第2回 3／7）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
ています。また、加熱式たばこ使用者も健康保険による禁煙治療の対象として認められ
ています。
【参考文献】
1. Ikeda N., et al. Adult mortality attributable to preventable risk factors for noncommunicable diseases and injuries in Japan: a comparative risk assessment.
PLoS Med 2012; 9: e1001160.
2. Hozawa A., et al. Joint impact of smoking and hypertension on cardiovascular
disease and all-cause mortality in Japan: NIPPON DATA80, a 19-year followup. Hypertens Res 2007; 30: 1169-1175.
3. Yamagishi K., et al. Smoking raises the risk of total and ischemic strokes in
hypertensive men. Hypertens Res 2003; 26: 209-217.
4. Craig WY., et al. Cigarette smoking and serum lipid and lipoprotein
concentrations: an analysis of published data. Br Med J. 1989; 298: 784-788.
5. U.S. Department of Health and Human Services. How Tobacco Smoke Causes
Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease:
A Report of the Surgeon General, 2010.
6. Nakamura K., et al. Influence of smoking combined with another risk factor on
the risk of mortality from coronary heart disease and stroke: pooled analysis of
10 Japanese cohort studies. Cerebrovasc Dis. 2012; 33: 480-491.
7. Willi C., et al. Active smoking and the risk of type 2 diabetes: a systematic review
and meta-analysis. JAMA 2007; 298: 2654-2664.
8. Cryer PE., et al. Norepinephrine and epinephrine release and adrenergic
mediation of smoking-associated hemodynamic and metabolic events. N Engl
J Med 1976; 295: 573-577.
9. Chiolero A., et al. Consequences of smoking for body weight, body fat
distribution, and insulin resistance. Am J Clin Nutr 2008; 87: 801-809.
10.佐々木陽 ほか. 15 年にわたるインスリン非依存糖尿病（ＮIDDM）の追跡調査. 糖尿病
1996; 39: 503-509.
11.Al-Delaimy WK., et al. Smoking and mortality among women with type 2
diabetes: The Nurses' Health Study cohort. Diabetes Care. 2001; 24: 20432048.
12.De Cosmo S., et al. Cigarette smoking is associated with low glomerular
filtration rate in male patients with type 2 diabetes. Diabetes Care. 2006; 29:
2467- 2470.
13.Nakanishi N., et al. Cigarette smoking and the risk of the metabolic syndrome
in middle-aged Japanese male office workers. Ind Health 2005; 43: 295-301.
14.Higashiyama A., et al. Risk of smoking and metabolic syndrome for incidence
of cardiovascular disease-comparison of relative contribution in urban
Japanese population: the Suita study. Circ J 2009; 73: 2258-2263.
15.Kasza KA, et al. Effectiveness of stop-smoking medications: findings from the
International Tobacco Control (ITC) Four Country Survey. Addiction, 2013;
108: 193-202.
16.日本循環器学会, 日本肺癌学会, 日本癌学会, 日本呼吸器学会. 禁煙治療のための標準
手順書 第 6 版. 2014
138
ています。
【参考文献】
1. Ikeda N., et al. Adult mortality attributable to preventable risk factors for noncommunicable diseases and injuries in Japan: a comparative risk assessment.
PLoS Med 2012; 9: e1001160.
2. Hozawa A., et al. Joint impact of smoking and hypertension on cardiovascular
disease and all-cause mortality in Japan: NIPPON DATA80, a 19-year followup. Hypertens Res 2007; 30: 1169-1175.
3. Yamagishi K., et al. Smoking raises the risk of total and ischemic strokes in
hypertensive men. Hypertens Res 2003; 26: 209-217.
4. Craig WY., et al. Cigarette smoking and serum lipid and lipoprotein
concentrations: an analysis of published data. Br Med J. 1989; 298: 784-788.
5. U.S. Department of Health and Human Services. How Tobacco Smoke Causes
Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease:
A Report of the Surgeon General, 2010.
6. Nakamura K., et al. Influence of smoking combined with another risk factor on
the risk of mortality from coronary heart disease and stroke: pooled analysis of
10 Japanese cohort studies. Cerebrovasc Dis. 2012; 33: 480-491.
7. Willi C., et al. Active smoking and the risk of type 2 diabetes: a systematic review
and meta-analysis. JAMA 2007; 298: 2654-2664.
8. Cryer PE., et al. Norepinephrine and epinephrine release and adrenergic
mediation of smoking-associated hemodynamic and metabolic events. N Engl
J Med 1976; 295: 573-577.
9. Chiolero A., et al. Consequences of smoking for body weight, body fat
distribution, and insulin resistance. Am J Clin Nutr 2008; 87: 801-809.
10.佐々木陽 ほか. 15 年にわたるインスリン非依存糖尿病（ＮIDDM）の追跡調査. 糖尿病
1996; 39: 503-509.
11.Al-Delaimy WK., et al. Smoking and mortality among women with type 2
diabetes: The Nurses' Health Study cohort. Diabetes Care. 2001; 24: 20432048.
12.De Cosmo S., et al. Cigarette smoking is associated with low glomerular
filtration rate in male patients with type 2 diabetes. Diabetes Care. 2006; 29:
2467- 2470.
13.Nakanishi N., et al. Cigarette smoking and the risk of the metabolic syndrome
in middle-aged Japanese male office workers. Ind Health 2005; 43: 295-301.
14.Higashiyama A., et al. Risk of smoking and metabolic syndrome for incidence
of cardiovascular disease-comparison of relative contribution in urban
Japanese population: the Suita study. Circ J 2009; 73: 2258-2263.
15.Kasza KA, et al. Effectiveness of stop-smoking medications: findings from the
International Tobacco Control (ITC) Four Country Survey. Addiction, 2013;
108: 193-202.
16.日本循環器学会, 日本肺癌学会, 日本癌学会, 日本呼吸器学会. 禁煙治療のための標準
手順書 第 6 版. 2014
138